[
  {
    "ts": null,
    "headline": "Pfizer: The Patent Cloud Is An Opportunity For Bargain Hunters",
    "summary": "Pfizer offers value with a strong dividend, Metsera obesity expansion, PADCEV/Keytruda approval, and an oncology pipeline. Learn why PFE stock is a strong buy.",
    "url": "https://finnhub.io/api/news?id=45bec99e6244f2d256535d06c3fe89802b3203b30e23ea0869353406b9a5e253",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764483182,
      "headline": "Pfizer: The Patent Cloud Is An Opportunity For Bargain Hunters",
      "id": 137642940,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1292440985/image_1292440985.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Pfizer offers value with a strong dividend, Metsera obesity expansion, PADCEV/Keytruda approval, and an oncology pipeline. Learn why PFE stock is a strong buy.",
      "url": "https://finnhub.io/api/news?id=45bec99e6244f2d256535d06c3fe89802b3203b30e23ea0869353406b9a5e253"
    }
  }
]